Nicolas Chatain Selected Research

Dasatinib (BMS 354825)

5/2017

The SCLtTAxBCR-ABL transgenic mouse model closely reflects the differential effects of dasatinib on normal and malignant hematopoiesis in chronic phase-CML patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicolas Chatain Research Topics

Disease

12	Neoplasms (Cancer) 03/2024 - 01/2016
7	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023 - 02/2015
7	Primary Myelofibrosis (Myelosclerosis) 01/2023 - 01/2020
3	Fibrosis (Cirrhosis) 12/2023 - 01/2020
3	Leukemia 01/2019 - 02/2015
2	Eosinophilia 11/2022 - 01/2020
2	Systemic Mastocytosis 11/2022 - 01/2021
2	Polycythemia Vera 01/2021 - 01/2019
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2020 - 01/2018
1	Disease Progression 01/2023
1	Essential Thrombocythemia 01/2023
1	Malaria 12/2022
1	Pruritus (Itching) 11/2022
1	Philadelphia Chromosome 01/2021
1	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2017

Drug/Important Bio-Agent (IBA)

5	CalreticulinIBA 01/2024 - 01/2016
5	Tyrosine Kinase InhibitorsIBA 01/2023 - 05/2017
2	CytokinesIBA 01/2023 - 08/2020
2	Thrombopoietin ReceptorsIBA 11/2021 - 01/2016
1	Thrombopoietin (c-mpl Ligand)IBA 03/2024
1	CalciumIBA 03/2024
1	Erythropoietin FDA Link 03/2024
1	Zinc Finger Protein GLI1IBA 12/2023
1	imetelstatIBA 01/2023
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2023
1	A-factor (Streptomyces)IBA 01/2023
1	Antimalarials (Antimalarial Agents)IBA 12/2022
1	Lipocalin-2IBA 08/2021
1	Messenger RNA (mRNA)IBA 08/2021
1	nintedanibIBA 01/2021
1	Protein Subunit VaccinesIBA 01/2021
1	AntigensIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Monatide (IMS 3015)IBA 01/2021
1	Platelet Factor 4IBA 01/2021
1	VaccinesIBA 01/2021
1	SulfurIBA 10/2020
1	enzastaurinIBA 01/2020
1	EchinomycinIBA 01/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2020
1	Hypoxia-Inducible Factor 1IBA 01/2020
1	Leptin ReceptorsIBA 01/2020
1	Interferon-alpha (Interferon Alfa)IBA 01/2019
1	Lysine (L-Lysine)FDA Link 01/2019
1	InterferonsIBA 01/2019
1	MethyltransferasesIBA 01/2019
1	EnzymesIBA 01/2019
1	fms-Like Tyrosine Kinase 3IBA 01/2018
1	olaparibIBA 01/2018
1	talazoparibIBA 01/2018
1	Dasatinib (BMS 354825)FDA Link 05/2017
1	Janus Kinase 2IBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 02/2015
1	Oncogene Proteins (Oncogene Protein)IBA 02/2015

Therapy/Procedure

2	Therapeutics 10/2020 - 01/2019
1	Precision Medicine 11/2022
1	Stem Cell Transplantation 08/2020